Ontimetrials08 Nov, 2021Business
ON-TIME Clinical Trial As a Foundation dedicated to increasing awareness of MDS worldwide and sharing information. The primary purpose of this study is to compare overall survival (OS) in patients receiving rigosertib plus best supportive care (BSC) to OS of patients receiving BSC in a population of patients with MDS with excess blasts having failed, being intolerant, or relapsing after Vidaza azacitidine or Dacogen decitabine treatment.
F8bet | Link Trang Chủ F8 Bet
Nhà Cái Uy Tín
Supawood Architectural Lining Systems
Moxie Management
Lu88
Mm88
Fb88 | Nhà Cái Uy Tín Cá Cược
Vvvwin
789clubdorg
Greg’s Air Solutions Llc